番茄社区app

Learning to cope with stress and burnout on the job isn't the answer

Nasal spray now approved as monotherapy for treatment-resistant depression

Looking back, 5 years after COVID began

Population-based study found no higher risk than with another asthma and allergy medication class

News and commentary from the psychiatry world

A Q&A with a residency program director

Let's tap into our occupational and environmental medicine resources

News and commentary from the psychiatry world

Mood alterations may be common prodromal feature, case-control study suggests

Colorado is the second state to legalize psilocybin therapy

Treatments led to lower severity scores, meta-analysis suggests

Insurers review patients' progress to see whether they can go to a lower level of care

Completing eight sessions was not associated with decreased risk, however

Canada offers a cautionary tale